Advertisement
Screener

Carlsmed, Inc. (CARL) Deferred Offering Costs

2.8 / 5 stars · 68/120 Roast Me

Carlsmed, Inc. Deferred Offering Costs

Carlsmed, Inc. (CARL) had Deferred Offering Costs of $0 as of 2025-12-31, per its 10-K filed 2026-02-25.

Financial Statements › Balance Sheet › Assets › Assets, Current

us-gaap:DeferredOfferingCosts · last filed 2026-02-25

  • 2025-12-31: Deferred Offering Costs $0.00.
  • 2025-09-30: Deferred Offering Costs $0.00.
  • 2025-06-30: Deferred Offering Costs $3.80M.
  • 2024-12-31: Deferred Offering Costs $400.00K.
Period endDeferred Offering Costs
2025-12-31$0.00
10-K · filed 2026-02-25
2025-09-30$0.00
10-Q · filed 2025-11-06
2025-06-30$3.80M
10-Q · filed 2025-08-28
2024-12-31$400.00K
10-K · filed 2026-02-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Orthofix Medical Inc. (OFIX)$0.373B
ClearPoint Neuro, Inc. (CLPT)United States$0.446B-15.74
Orchestra BioMed Holdings, Inc. (OBIO)United States$0.356B-4.39
SHOULDER INNOVATIONS, INC. (SI)United States$0.355B
Sight Sciences, Inc. (SGHT)United States$0.478B-9.95
NeuroPace Inc (NPCE)United States$0.480B-28.52
Embecta Corp. (EMBC)United States$0.319B2.10
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
Mobia Medical, Inc. (MOBI)United States$0.293B
TACTILE SYSTEMS TECHNOLOGY INC (TCMD)United States$0.519B27.16